In last trading session, AEON Biopharma Inc (AMEX:AEON) saw 2.2 million shares changing hands with its beta currently measuring 0.05. Company’s recent per share price level of $0.12 trading at $0.0 or 1.25% at ring of the bell on the day assigns it a market valuation of $9.72M. That closing price of AEON’s stock is at a discount of -14208.33% from its 52-week high price of $17.17 and is indicating a premium of 16.67% from its 52-week low price of $0.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 76.81 million shares which gives us an average trading volume of 16.10 million if we extend that period to 3-months.
For AEON Biopharma Inc (AEON), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.18 in the current quarter.
AEON Biopharma Inc (AMEX:AEON) trade information
Upright in the green during last session for gaining 1.25%, in the last five days AEON remained trading in the red while hitting it’s week-highest on Friday, 01/24/25 when the stock touched $0.12 price level, adding 21.62% to its value on the day. AEON Biopharma Inc’s shares saw a change of -77.50% in year-to-date performance and have moved -5.08% in past 5-day. AEON Biopharma Inc (AMEX:AEON) showed a performance of -79.41% in past 30-days. Number of shares sold short was 0.16 million shares which calculate 1.6 days to cover the short interests.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
Insiders are in possession of 36.23% of company’s total shares while institution are holding 33.14 percent of that, with stock having share float percentage of 51.98%. Investors also watch the number of corporate investors in a company very closely, which is 33.14% institutions for AEON Biopharma Inc that are currently holding shares of the company.
